106 related articles for article (PubMed ID: 11790281)
1. Advancing perspectives on prostate cancer: multihormonal influences in pathogenesis.
Porter A; Ben-Josef E; Crawford ED; Garde S; Huhtaniemi I; Pontes JE
Mol Urol; 2001; 5(4):181-8. PubMed ID: 11790281
[TBL] [Abstract][Full Text] [Related]
2. Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo.
Garde S; Sheth A; Porter AT; Pienta KJ
Prostate; 1993; 22(3):225-33. PubMed ID: 8488155
[TBL] [Abstract][Full Text] [Related]
3. Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide.
Sheth AR; Garde SV; Mehta MK; Shah MG
Indian J Exp Biol; 1992 Mar; 30(3):157-61. PubMed ID: 1380948
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development.
Welt CK; Smith ZA; Pauler DK; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2531-7. PubMed ID: 11397851
[TBL] [Abstract][Full Text] [Related]
5. A study of the relative roles of follicle-stimulating hormone and luteinizing hormone in the regulation of testicular inhibin secretion in the rhesus monkey (Macaca mulatta).
Majumdar SS; Winters SJ; Plant TM
Endocrinology; 1997 Apr; 138(4):1363-73. PubMed ID: 9075690
[TBL] [Abstract][Full Text] [Related]
6. Abarelix Depot, a GnRH antagonist, v LHRH superagonists in prostate cancer: differential effects on follicle-stimulating hormone. Abarelix Depot study group.
Garnick MB; Campion M
Mol Urol; 2000; 4(3):275-7. PubMed ID: 11062384
[TBL] [Abstract][Full Text] [Related]
7. A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions.
Allan CM; Haywood M; Swaraj S; Spaliviero J; Koch A; Jimenez M; Poutanen M; Levallet J; Huhtaniemi I; Illingworth P; Handelsman DJ
Endocrinology; 2001 Jun; 142(6):2213-20. PubMed ID: 11356665
[TBL] [Abstract][Full Text] [Related]
8. Endocrine control of prostate cancer.
Wilding G
Cancer Surv; 1995; 23():43-62. PubMed ID: 7621473
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles.
Welt CK; Schneyer AL
J Clin Endocrinol Metab; 2001 Jan; 86(1):330-6. PubMed ID: 11232020
[TBL] [Abstract][Full Text] [Related]
10. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
11. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
12. Possible role of luteinizing hormone and follicle-stimulating hormone in modulating inhibin secretion and expression during the estrous cycle of the rat.
Rivier C; Roberts V; Vale W
Endocrinology; 1989 Aug; 125(2):876-82. PubMed ID: 2502378
[TBL] [Abstract][Full Text] [Related]
13. An inverse relationship exists between seminal plasma inhibin and serum follicle-stimulating hormone in man.
Scott RS; Burger HG
J Clin Endocrinol Metab; 1981 Apr; 52(4):796-803. PubMed ID: 6782118
[TBL] [Abstract][Full Text] [Related]
14. Differential storage and release of luteinizing hormone and follicle-releasing hormone from individual gonadotropes separated by centrifugal elutriation.
Lloyd JM; Childs GV
Endocrinology; 1988 Apr; 122(4):1282-90. PubMed ID: 3126034
[TBL] [Abstract][Full Text] [Related]
15. Prostate--a novel target for evaluation of FSH modulating peptides.
Shah MG; Hurkadli KS; Garde SV; Sheth AR
Indian J Exp Biol; 1991 Feb; 29(2):101-4. PubMed ID: 1907946
[TBL] [Abstract][Full Text] [Related]
16. Regulation of inhibin subunit messenger ribonucleic acid levels by gonadotropins, growth factors, and gonadotropin-releasing hormone in cultured rat granulosa cells.
LaPolt PS; Piquette GN; Soto D; Sincich C; Hsueh AJ
Endocrinology; 1990 Aug; 127(2):823-31. PubMed ID: 2115434
[TBL] [Abstract][Full Text] [Related]
17. Inhibin concentrations in ovarian and jugular venous plasma and the relationship of inhibin with follicle-stimulating hormone and luteinizing hormone during the ovine estrous cycle.
Findlay JK; Clarke IJ; Robertson DM
Endocrinology; 1990 Jan; 126(1):528-35. PubMed ID: 2104590
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of the follicle-stimulating hormone (FSH)-inhibin B feedback loop and its role in regulating spermatogenesis in the adult male rhesus monkey (Macaca mulatta) as revealed by unilateral orchidectomy.
Ramaswamy S; Marshall GR; McNeilly AS; Plant TM
Endocrinology; 2000 Jan; 141(1):18-27. PubMed ID: 10614619
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of gonadotropins before and after prostate ablation in cancer patients.
Yu G; Mylander C; Traish A; Jarrett T
Horm Mol Biol Clin Investig; 2012 Oct; 11(3):355-62. PubMed ID: 25436695
[TBL] [Abstract][Full Text] [Related]
20. Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR).
Ben-Josef E; Yang SY; Ji TH; Bidart JM; Garde SV; Chopra DP; Porter AT; Tang DG
J Urol; 1999 Mar; 161(3):970-6. PubMed ID: 10022736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
